SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pharmos (PARS)
An SI Board Since October 1998
Posts SubjectMarks Bans Symbol
1386 42 0 PARS
Emcee:  Dr. John M. de Castro Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
361 "turning profitable"............yosi s-12/22/1998
360 Special Health Care Edition of The Wall Street Transcript. Interviews with elevRick Strange-12/22/1998
359 Ariella, I agree with you entirely. Clearly, the current stock price does not Zvi Steinberg-12/21/1998
358 Zvi -- my "gut" says Novartis will make the short list for candidatesAriella-12/21/1998
357 Moreover, this is good news because Dr. guttman brings big pharma "legitimZvi Steinberg-12/21/1998
356 More important -- PARS in the news ;-) biz.yahoo.com Guess management is bAriella-12/21/1998
355 AMGEN in the news Should be good for biotechs go2net.newsalert.comyosi s-12/21/1998
354 We have had amazingly bad karma on news releases this past year... Our long-awaAriella-12/20/1998
353 ALL QUIET ON THE PHARMOS FRONT--Budget Anxiety Allayed in Thread Participants Cj_fir2-12/16/1998
352nytimes.com Decline in Investment Forces Biotech Industry to Scale Back (myosi s-12/16/1998
351globes.co.ilMr. Proofsheet-12/15/1998
350 Tom, You just don't get it do you ? PARS just got a great deal and you'Omer Shvili-12/15/1998
349 Ariella, others- Re: Equity line of credit- are there any restrictions on theTony van Werkhooven-12/15/1998
348 I think it is a good deal for Pharmos but I'm also thinking that investmentGabe Fernandez-12/14/1998
347 Tom, I suggested a short-term rights offering a few times in the past and I donRick Strange-12/14/1998
346 Ariella, yosi s: On reflection, and with a little prodding via p.m. from my frtom pope-12/14/1998
345 Let's put our thinking caps on about this news release. <<Pharmos CoAriella-12/14/1998
344 In the deal Pharmos has a line of credit. it will chose how much to draw and wyosi s-12/14/1998
343 Hello, Don I didn't mean to imply it was a bad deal for PARS. Only that itom pope-12/14/1998
342 Hi Tom! Based on today's closing price 7% is .11 or 11 cents per share. ThDon Walster-12/14/1998
341 Dear Ariella, Wouldn't you be delighted to buy PARS stock at a 7% discounttom pope-12/14/1998
340 " one that is supportive with as little dilution as is necessary.&celeryroot.com-12/14/1998
339 Very creative financing package just announced for $10 million! The CFO has comAriella-12/14/1998
338 Yosi: It's not clear to me why a partner would wait until the 3rd cohort isarnie h-12/13/1998
337 Anyone contacted Pharmos about the timing of when they expect to raise more monLucky-12/13/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News